tumor-infiltrating lymphocyte 腫瘤浸潤淋巴細胞

tumor-infiltrating lymphocyte
繁：腫瘤浸潤淋巴細胞
简：肿瘤浸润淋巴细胞

據報，美國一名乳癌病情已屆末期，癌細胞已擴散至肝臟及其他器官的女病人，獲挑選參加免疫療法試驗計劃（T細胞輸入療法），利用其自身「腫瘤浸潤淋巴細胞」（TILs，內含T細胞）抗癌，配合協助免疫系統攻擊癌細胞藥物治療。

立法會十八題：乳癌的預防及治療（2018年6月20日）。香港特別行政區政府新聞公報，取自 http://www.info.gov.hk/gia/general/201806/20/P2018062000639.htm

It has been reported that in the United States, a female terminal breast cancer patient whose cancer cells had spread to the liver and other organs was selected for participation in an immunotherapy trial (adoptive cell transfer (ACT) therapy), which enlisted her own “tumor-infiltrating lymphocytes” (TILs which contained T cells) to fight against the cancer, coupled with drug treatment which assisted her immune system in attacking cancer cells.

LCQ18: Prevention and treatment of breast cancer. (2018, June 20). HKSAR Press Releases. Retrieved from http://www.info.gov.hk/gia/general/201806/20/P2018062000637.htm?fontSize=1